Annual Total Long Term Liabilities
$367.67 M
+$286.06 M+350.52%
December 1, 2023
Summary
- As of February 23, 2025, BCAX annual total long term liabilities is $367.67 million, with the most recent change of +$286.06 million (+350.52%) on December 1, 2023.
- During the last 3 years, BCAX annual total long term liabilities has risen by +$286.06 million (+350.52%).
- BCAX annual total long term liabilities is now at all-time high.
Performance
BCAX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$137.00 K
-$367.36 M-99.96%
September 30, 2024
Summary
- As of February 23, 2025, BCAX quarterly total long term liabilities is $137.00 thousand, with the most recent change of -$367.36 million (-99.96%) on September 30, 2024.
- BCAX quarterly long term liabilities is now -99.96% below its all-time high of $367.67 million, reached on December 1, 2023.
Performance
BCAX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BCAX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +350.5% | - |
| 3 y3 years | +350.5% | - |
| 5 y5 years | +350.5% | - |
BCAX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +350.5% | -100.0% | at low |
| 5 y | 5-year | at high | +350.5% | -100.0% | at low |
| alltime | all time | at high | +350.5% | -100.0% | at low |
Bicara Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $137.00 K(-100.0%) |
| Jun 2024 | - | $367.49 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $367.67 M(+350.5%) | $367.67 M |
| Dec 2022 | $81.61 M | - |
FAQ
- What is Bicara Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Bicara Therapeutics?
- What is Bicara Therapeutics annual total long term liabilities year-on-year change?
- What is Bicara Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Bicara Therapeutics?
What is Bicara Therapeutics annual total long term liabilities?
The current annual total long term liabilities of BCAX is $367.67 M
What is the all time high annual total long term liabilities for Bicara Therapeutics?
Bicara Therapeutics all-time high annual total long term liabilities is $367.67 M
What is Bicara Therapeutics annual total long term liabilities year-on-year change?
Over the past year, BCAX annual total long term liabilities has changed by +$286.06 M (+350.52%)
What is Bicara Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of BCAX is $137.00 K
What is the all time high quarterly long term liabilities for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly total long term liabilities is $367.67 M